PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-0.75%
Negative net income growth while MRVL stands at 209.30%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
6.67%
Some D&A expansion while MRVL is negative at -1.26%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-90.38%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-28.83%
Negative yoy SBC while MRVL is 1.11%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
98.82%
Well above MRVL's 93.80% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
74.68%
AR growth while MRVL is negative at -1.60%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
59.41%
Inventory growth well above MRVL's 30.75%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
-63.51%
Negative yoy AP while MRVL is 34.26%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
359.38%
Growth well above MRVL's 412.01%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
61.63%
Some yoy increase while MRVL is negative at -95.95%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
38.46%
Operating cash flow growth above 1.5x MRVL's 23.98%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-3.39%
Negative yoy CapEx while MRVL is 36.70%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
23.89%
Purchases growth of 23.89% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-5.87%
We reduce yoy sales while MRVL is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-111.90%
Both yoy lines negative, with MRVL at -4700.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
28.97%
Lower net investing outflow yoy vs. MRVL's 60.05%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
100.00%
We repay more while MRVL is negative at -149.73%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
4.62%
Issuance growth of 4.62% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
41.77%
Buyback growth of 41.77% while MRVL is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.